CCL17 and neoplasm: Tumor gene expression analysis performed 7 days post Imprime dosing showed upregulation of M1 markers, e.g., Nos2, Il12b, and Tnfa, along with downregulation of M2-associated genes including Arg1 and Ccl17 (Supplementary Figure 3B).